Loading company…
Herzliya-based biopharmaceutical company acquiring and developing late-stage pharmaceutical products for rare and chronic diseases.
XTL Biopharmaceuticals Ltd. is based in Herzliya, Israel, and focuses on acquiring and developing late-stage pharmaceutical candidates, particularly for rare diseases and chronic conditions. Shlomo Shalev serves as CEO. The company raised USD 4.00 mn in financing on March 31, 2015. In 2012 it reported revenue of USD 938,000.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in